Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jon Waarst Gregersen"'
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-6 (2019)
Abstract Background An increased incidence of thromboembolic events (TE) are reported in nephrotic syndrome (NS) leading to recommendations for prophylactic anticoagulation (PAC). However, as no randomized clinical trial has established the efficacy
Externí odkaz:
https://doaj.org/article/580d645001d84888b6f1a279ad1a72a7
Autor:
Louis Nygaard, Christoffer Polcwiartek, Karl Emil Nelveg-Kristensen, Nicholas Carlson, Salome Kristensen, Christian Torp-Pedersen, Jon Waarst Gregersen
Publikováno v:
Nygaard, L, Polcwiartek, C, Nelveg-Kristensen, K E, Carlson, N, Kristensen, S, Torp-Pedersen, C & Gregersen, J W 2023, ' Long-term cardiovascular outcomes and temporal trends in patients diagnosed with ANCA-associated vasculitis : a Danish nationwide registry study ', Rheumatology, vol. 62, no. 2, keac386, pp. 735-746 . https://doi.org/10.1093/rheumatology/keac386
Objectives To examine long-term cardiovascular outcomes and temporal trends among patients with ANCA-associated vasculitis (AAV) using Danish nationwide registries. Methods Using a cohort design, we examined patients with granulomatosis with polyangi
Autor:
Louis Nygaard Pedersen, Christoffer Polcwiartek, Karl-Emil Nelveg-Kristensen, Nicholas Carlson, Salome Kristensen, Christian Torp-Pedersen, Jon Waarst Gregersen
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Antineutrophil cytoplasmic antibody associated vasculitis (AAV) is a group of autoimmune systemic inflammatory diseases, with cardiovascular disease being the leading cause of death. However, large-scale real-world data on the ris
Autor:
Nicholas Carlson, David Jayne, Per Ivarsen, Hans Dieperink, Christian Torp-Pedersen, Martin Egfjord, Jon Waarst Gregersen, Wladimir Szpirt, Elizabeth Krarup, Mark McClure, Karl Emil Nelveg-Kristensen
Publikováno v:
Nelveg-Kristensen, K E, Szpirt, W, Carlson, N, McClure, M, Jayne, D, Dieperink, H, Gregersen, J W, Krarup, E, Ivarsen, P, Torp-Pedersen, C & Egfjord, M 2022, ' Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study ', Nephrology, Dialysis, Transplantation, vol. 37, no. 1, pp. 63–71 . https://doi.org/10.1093/ndt/gfaa303
Nelveg-Kristensen, K E, Szpirt, W, Carlson, N, McClure, M, Jayne, D, Dieperink, H, Gregersen, J W, Krarup, E, Ivarsen, P, Torp-Pedersen, C & Egfjord, M 2022, ' Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study ', Nephrology, Dialysis, Transplantation, vol. 37, no. 1, pp. 63-71 . https://doi.org/10.1093/ndt/gfaa303
Nelveg-Kristensen, K E, Szpirt, W, Carlson, N, McClure, M, Jayne, D, Dieperink, H, Gregersen, J W, Krarup, E, Ivarsen, P, Torp-Pedersen, C & Egfjord, M 2022, ' Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study ', Nephrology, Dialysis, Transplantation, vol. 37, no. 1, gfaa303, pp. 63-71 . https://doi.org/10.1093/ndt/gfaa303
Nelveg-Kristensen, K E, Szpirt, W, Carlson, N, McClure, M, Jayne, D, Dieperink, H, Gregersen, J W, Krarup, E, Ivarsen, P, Torp-Pedersen, C & Egfjord, M 2022, ' Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study ', Nephrology, Dialysis, Transplantation, vol. 37, no. 1, pp. 63-71 . https://doi.org/10.1093/ndt/gfaa303
Nelveg-Kristensen, K E, Szpirt, W, Carlson, N, McClure, M, Jayne, D, Dieperink, H, Gregersen, J W, Krarup, E, Ivarsen, P, Torp-Pedersen, C & Egfjord, M 2022, ' Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study ', Nephrology, Dialysis, Transplantation, vol. 37, no. 1, gfaa303, pp. 63-71 . https://doi.org/10.1093/ndt/gfaa303
Background Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) carries a high risk of morbidity and mortality, with outcomes modified by treatment and an incidence that may be increasing. We examined temporal changes in incidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fca7ea53f9911602ab4949d74546688
https://vbn.aau.dk/da/publications/0b46cd0d-9142-44dc-8834-af6016de4541
https://vbn.aau.dk/da/publications/0b46cd0d-9142-44dc-8834-af6016de4541
Autor:
Lene Dreyer, Vibeke Strand, Søren Jacobsen, H. Leffers, Peter C. Taylor, Robin Christensen, Jon Waarst Gregersen, Julie F Pedersen, Simone Høstgaard, Line Uhrenholt, Anne Voss, Salome Kristensen
Publikováno v:
Uhrenholt, L, Høstgaard, S, Pedersen, J F, Christensen, R, Dreyer, L, Leffers, H C B, Taylor, P C, Strand, V, Jacobsen, S, Voss, A, Gregersen, J W & Kristensen, S 2021, ' Patient-reported outcome measures in systemic lupus erythematosus by a web-based application : A randomized, crossover, agreement study ', Lupus, vol. 30, no. 13, pp. 2124-2134 . https://doi.org/10.1177/09612033211051641
Objectives Patient-reported outcome measures (PROMs) are evaluated in randomized controlled trials (RCTs) in patients with systemic lupus erythematosus (SLE), but not widely used in clinical practice. However, interest in incorporating PROMs into the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d5d5f193ba23ef4e16241781fa06cf6
https://vbn.aau.dk/da/publications/5078fdfc-0da9-498e-918d-55f70f0f5dac
https://vbn.aau.dk/da/publications/5078fdfc-0da9-498e-918d-55f70f0f5dac
Autor:
Wladimir Szpirt, Per Ivarsen, Nicholas Carlson, Elizabeth Krarup, Christian Torp-Pedersen, Martin Egfjord, Karl Emil Nelveg-Kristensen, Jon Waarst Gregersen
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Double positivity of anti-GBM and ANCA serology is uncommon but may represent a distinct disease entity of small vessel vasculitis. Previous research has been challenged by low disease incidence, and conflicting results pertaining
Autor:
Martin Egfjord, Christian Torp-Pedersen, Elizabeth Krarup, Gunnar Gislason, Jon Waarst Gregersen, Wladimir Szpirt, Karl-Emil Nelveg-Kristensen, Per Ivarsen, Hans Dieperink, Nicholas Carlson
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Anti-neutrophil cytoplasmic antibody associated vasculitis (AAV) defines an uncommon group of autoimmune diseases with antibodies directed against proteinase 3 (PR3) or myeloperoxidase (MPO). Incidence rates of PR3- and MPO-AAV di
Autor:
Ib Tønder Hansen, Jon Waarst Gregersen, Per Ivarsen, Kresten Krarup Keller, Bjarne Kuno Møller, Elizabeth Krarup, Christian Erikstrup, Rie Io Glerup
Publikováno v:
Gregersen, J W, Erikstrup, C, Ivarsen, P, Glerup, R, Krarup, E, Keller, K K, Hansen, I T & Møller, B K 2019, ' PR3-ANCA-associated vasculitis is associated with a specific motif in the peptide-binding cleft of HLA-DP molecules ', Rheumatology, vol. 58, no. 11, pp. 1942-1949 . https://doi.org/10.1093/rheumatology/kez111
Waarst Gregersen, J, Erikstrup, C, Ivarsen, P, Glerup, R, Krarup, E, Keller, K K, Hansen, I T & Møller, B K 2019, ' PR3-ANCA-associated vasculitis is associated with a specific motif in the peptide-binding cleft of HLA-DP molecules ', Rheumatology, vol. 58, no. 11, pp. 1942-1949 . https://doi.org/10.1093/rheumatology/kez111
Waarst Gregersen, J, Erikstrup, C, Ivarsen, P, Glerup, R, Krarup, E, Keller, K K, Hansen, I T & Møller, B K 2019, ' PR3-ANCA-associated vasculitis is associated with a specific motif in the peptide-binding cleft of HLA-DP molecules ', Rheumatology, vol. 58, no. 11, pp. 1942-1949 . https://doi.org/10.1093/rheumatology/kez111
Objectives This study aimed to characterize the association between HLA alleles and ANCA-associated vasculitis (AAV) in a genetically homogeneous population, and to analyse the contribution of specific HLA molecule amino acid sequences to the risk of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6195d24e98400e6aa7f79e7f4608e29
https://vbn.aau.dk/da/publications/f65f175c-c746-4274-bd27-df0819d7291f
https://vbn.aau.dk/da/publications/f65f175c-c746-4274-bd27-df0819d7291f
Publikováno v:
Wen, L, Zhao, Z, Wang, Z, Xiao, J, Birn, H & Gregersen, J W 2019, ' High levels of urinary complement proteins are associated with chronic renal damage and proximal tubule dysfunction in immunoglobulin A nephropathy ', Nephrology (Carlton, Vic.), vol. 24, no. 7, pp. 703-710 . https://doi.org/10.1111/nep.13477
Wen, L, Zhao, Z, Wang, Z, Xiao, J, Birn, H & Gregersen, J W 2019, ' High levels of urinary complement proteins are associated with chronic renal damage and proximal tubule dysfunction in immunoglobulin A nephropathy ', Nephrology, vol. 24, no. 7, pp. 703-710 . https://doi.org/10.1111/nep.13477
Wen, L, Zhao, Z, Wang, Z, Xiao, J, Birn, H & Gregersen, J W 2019, ' High levels of urinary complement proteins are associated with chronic renal damage and proximal tubule dysfunction in immunoglobulin A nephropathy ', Nephrology, vol. 24, no. 7, pp. 703-710 . https://doi.org/10.1111/nep.13477
Aim Complement activation is involved in the pathogenesis and progression of immunoglobulin A nephropathy (IgAN); however, the clinical implication of abnormal complement protein levels in serum and urine is not clear. To address this we analyzed the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e3f66b6e70917720db161f1f90b16a5
https://vbn.aau.dk/da/publications/3307c404-a257-4960-aa6c-919f0b9cea71
https://vbn.aau.dk/da/publications/3307c404-a257-4960-aa6c-919f0b9cea71
Publikováno v:
BMC Nephrology
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, 139, pp. 1-6 . https://doi.org/10.1186/s12882-019-1336-8
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, 139 . https://doi.org/10.1186/s12882-019-1336-8
BMC Nephrology, Vol 20, Iss 1, Pp 1-6 (2019)
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, pp. 139 . https://doi.org/10.1186/s12882-019-1336-8
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, 139, pp. 1-6 . https://doi.org/10.1186/s12882-019-1336-8
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, 139 . https://doi.org/10.1186/s12882-019-1336-8
BMC Nephrology, Vol 20, Iss 1, Pp 1-6 (2019)
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, pp. 139 . https://doi.org/10.1186/s12882-019-1336-8
BACKGROUND: An increased incidence of thromboembolic events (TE) are reported in nephrotic syndrome (NS) leading to recommendations for prophylactic anticoagulation (PAC). However, as no randomized clinical trial has established the efficacy or risks